Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
The 2025-2030 World Outlook for Mono Hepatitis B Vaccines
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The World Market for Vaccines, 2024
... adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related ... Read More
-
Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User - Global Forecast to 2029
... The lateral flow assays market is valued at an estimated USD 10.8 billion in 2023 and is projected treach USD 16.8 billion by 2029, at a CAGR of 7.6% during the forecast period. The rising ... Read More
-
Infectious Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV, Others), By End Use (Hospitals, Clinics, Others), By Region, and By Competition
... Competition Global Infectious Disease Therapeutics Market was valued at USD 67.04 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.00% through 2029. The Global Infectious ... Read More
-
Protease Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Disease indication (HIV/AIDS, Hepatitis C, Alpha-1 Antitrypsin Deficiency, Hereditary Angioedema (HAE), Others), By End-Use (Hospitals & Clinics, Research Laboratories and Academic Institutes, Others) Region and Competition
... Academic Institutes, Others) Region and Competition Global Protease Inhibitors Market was valued at USD 6.21 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 4.16% through ... Read More
-
Hepatitis C - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... pandemic significantly impacted the hepatitis C market and influenced the market growth rate during the pandemic phase. For instance, according to a study published by the Journal of Managed Care & Specialty Pharmacy in June ... Read More
-
Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... to reach USD 5.91 billion by 2029, growing at a CAGR of 5.67% during the forecast period (2024-2029). The impact of COVID-19 in its initial phase was adverse owing to cancellations of diagnostic procedures worldwide. ... Read More
-
APAC PCR-based Infectious Diseases Market - Industry Trends and Forecast to 2032
... a CAGR of 7.4% in the forecast period of 2024 to 2031. Market Segmentation Asia-Pacific PCR-based Infectious Diseases Market, By Test Type (Tuberculosis PCR Test, Hepatitis PCR Test, Human Immunodeficiency Virus (HIV) PCR Test, Influenza ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032 The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market ... Read More
-
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2024-2032
... vaccines market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.6% during 2024-2032. The market is ... Read More
-
Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2024-2032
... the market to reach US$ 8.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032. The market is experiencing robust growth, driven by the rising prevalence of hepatitis across the globe, rapid ... Read More
-
Hepatitis B Virus (HBV) Global Market Report 2024
... Healthcare PayersCovering: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmon La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc. Hepatitis B Virus (HBV) Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Liver Disease Diagnostics Market Size - By Disease Type (Hepatitis, Cirrhosis, Liver Cancer, Non-Alcoholic Fatty Liver Disease (NAFLD)), Technique (Imaging, Liver Biopsy, Endoscopy, Lab Test), End-use - Global Forecast (2024 - 2032)
... Diagnostics Market is expected to register a CAGR of 7.3% between 2024-2032, fueled by technological advancements, rising prevalence of liver diseases, and increasing awareness about early diagnosis. According to WHO, globally, 354 million individuals are ... Read More
-
Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Global Forecast 2024-2030
... to reach USD 93.56 billion in 2024, at a CAGR 10.73% to reach USD 173.25 billion by 2030. Global Specialty Generics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Specialty ... Read More
-
Antiviral Drugs Market by Drug Type (Branded Drugs, Generic Drugs), Therapeutics (Acquired Immunodeficiency Syndrome Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics), End Use - Global Forecast 2024-2030
... at USD 56.22 billion in 2023 and expected to reach USD 59.84 billion in 2024, at a CAGR 6.54% to reach USD 87.61 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Diagnostic Specialty Antibodies Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), Application (Dengue Diagnostics, Hepatitis Diagnosis, HIV Diagnostics), End User - Global Forecast 2024-2030
... USD 23.11 billion in 2023 and expected to reach USD 24.36 billion in 2024, at a CAGR 5.49% to reach USD 33.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Zoonotic Disease Treatment Market by Disease Type (Rabies, Tuberculosis, Viral Hepatitis), Drug Class (Antibacterial Medication, Antibiotics) - Global Forecast 2024-2030
... expected to reach USD 42.99 billion in 2024, at a CAGR 5.45% to reach USD 59.18 billion by 2030. Global Zoonotic Disease Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Global Forecast 2024-
... size was estimated at USD 3.53 billion in 2023 and expected to reach USD 3.71 billion in 2024, at a CAGR 5.48% to reach USD 5.13 billion by 2030.The hepatitis test solutions/ diagnosis are used ... Read More
-
Hepatitis Therapeutics Market by Type (Hepatitis A, Hepatitis B, Hepatitis C), Drug Class (Immune Modulator, Oral Antiviral), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 30.76 billion in 2024, at a CAGR 4.11% to reach USD 38.71 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hepatitis Therapeutics ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Hepatitis Therapeutics Global Market Report 2024
... ProvidersCovering: Gilead Sciences Inc.; Bristol-Myers Squibb Co.; AbbVie Inc.; Merck & Co. Inc.; Johnson & Johnson Services Inc. Hepatitis Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Global Viral Hepatitis and Retrovirus Diagnostic Tests Market Research Report 2024(Status and Outlook)
... performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in ... Read More
-
Global Hepatitis B Vaccines Market Research Report 2024(Status and Outlook)
... in 2023 and is projected to reach USD 1161.93 million by 2029, exhibiting a CAGR of 1.80% during the forecast period. This report provides a deep insight into the global Hepatitis B Vaccines market covering ... Read More
-
Global Hepatitis A Vaccination Market Research Report 2024(Status and Outlook)
... HAV infection, Minimum age for HAV vaccination is 1 year. The Global Hepatitis A Vaccination Market Size was estimated at USD 754.91 million in 2023 and is projected to reach USD 860.20 million by 2029, ... Read More
-
Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
... Others),Regional Outlook– Global Forecast up to 2030 For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders ... Read More
Research Assistance
